Christopher P. Regan

Author

Also Known As

C P Regan, C. P. Regan, C. Regan, Chris Regan, Christopher P. Regan, Christopher P Regan, Christopher P. Regan, Christopher Regan

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)University of Virginia University of Alabama at Birmingham

About

Christopher P. Regan is an author at United States Military Academy specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.2K
2	Anesthesia	4	4	70
3	Health Sciences	3	3	70
4	Social Sciences	3	3	309
5	Public Health	2	2	36

Christopher P. Regan

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Selective activation of the M <sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation Lei Ma, Matthew A. Seager, Marion Wittmann, Proceedings of the National Academy of Sciences Synaptic TransmissionNeurotransmitterSelective ActivationSocial SciencesMolecular Pharmacology	2009	282
Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor β Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22α in Vivo Paul J. Adam, Christopher P. Regan, Martina B. Hautmann, Journal of Biological Chemistry Cell GrowthCellular PhysiologyTranscriptional RegulationSignaling PathwayProtein Expression	2000	243
Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects Christopher P. Regan, Wei Li, Diane M. Boucher, Proceedings of the National Academy of Sciences Cardiac MuscleVascular DiseaseVascular MalformationCongenital Heart AnomalyEmbryonic Cardiovascular Defects	2002	240
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury Christopher P. Regan, Paul J. Adam, Cort S. Madsen, Journal of Clinical Investigation	2000	232
Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells Joan M. Taylor, Christopher P. Mack, Kate Nolan, Molecular and Cellular Biology	2001	157
Smooth Muscle–Specific Expression of the Smooth Muscle Myosin Heavy Chain Gene in Transgenic Mice Requires 5′-Flanking and First Intronic DNA Sequence Cort S. Madsen, Christopher P. Regan, Jill E. Hungerford, Circulation Research	1998	152
Design and Synthesis of Novel Isoquinoline-3-nitriles as Orally Bioavailable Kv1.5 Antagonists for the Treatment of Atrial Fibrillation B. Wesley Trotter, Kausik K. Nanda, Nathan R. Kett, Journal of Medicinal Chemistry Medicinal ChemistryOral BioavailabilityPharmaceutical ScienceKv1.5 Potassium ChannelIsoquinolinone Lead 1	2006	97
Development of a Smooth Muscle–Targeted Cre Recombinase Mouse Reveals Novel Insights Regarding Smooth Muscle Myosin Heavy Chain Promoter Regulation Christopher P. Regan, Ichiro Manabe, Gary K. Owens Circulation Research	2000	90
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist Christopher Salvatore, Eric L. Moore, Amy Calamari, Journal of Pharmacology and Experimental Therapeutics	2010	88
Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor Eric L. Moore, Mark E. Fraley, Ian M. Bell, Journal of Pharmacology and Experimental Therapeutics	2020	70

Page 1